Medicare Enrolled
Dr. Flavio Alvarez, MD
Emergency Medicine · Live Oak, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alvarez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alvarez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alvarez
Dr. Flavio Alvarez is an emergency medicine specialist in Live Oak, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alvarez performed 1,975 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Alvarez received a total of $10,390 from 45 pharmaceutical and/or device companies across 391 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alvarez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in TX
$10,390 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,975
Medicare services
Top 2% in TX for emergency medicine
Not available
Unique patients (not deduplicated)
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
392 | $45 | $100 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
389 | $262 | $649 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
329 | $68 | $237 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
262 | $60 | $140 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
155 | $36 | $75 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
93 | $223 | $539 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
83 | $91 | $202 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
59 | $195 | $538 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
49 | $47 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
45 | $127 | $391 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
42 | $67 | $203 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
34 | $100 | $263 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $106 | $334 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
13 | $2 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $41 | $167 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,390
Total received (2018-2024)
Avg $1,484/year across 7 years
Top 3% in TX for emergency medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
391
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,100
2023
$1,612
2022
$2,919
2021
$978
2020
$165
2019
$1,196
2018
$1,421
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$377
Aurinia Pharma U.S., Inc.
$303
Amgen Inc.
$231
Ardelyx, Inc.
$189
Fresenius USA Marketing, Inc.
$162
VentureMed Group, Inc.
$153
Bayer Healthcare Pharmaceuticals Inc.
$145
CorMedix Inc.
$88
Novartis Pharmaceuticals Corporation
$86
Otsuka America Pharmaceutical, Inc.
$74
Mallinckrodt Hospital Products Inc.
$60
Travere Therapeutics, Inc.
$58
Novo Nordisk Inc
$54
OPKO Pharmaceuticals, LLC
$44
ANI Pharmaceuticals, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
CALLIDITAS THERAPEUTICS US INC.
$18
GlaxoSmithKline, LLC.
$18
Top 3 companies account for 43.4% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$2,029
AstraZeneca Pharmaceuticals LP
$1,333
Otsuka America Pharmaceutical, Inc.
$763
Fresenius USA Marketing, Inc.
$643
Aurinia Pharma U.S., Inc.
$625
OPKO Pharmaceuticals, LLC
$561
Amgen Inc.
$513
Bayer Healthcare Pharmaceuticals Inc.
$448
BAXTER HEALTHCARE
$252
FRESENIUS USA INC.
$250
Novartis Pharmaceuticals Corporation
$229
Horizon Therapeutics plc
$197
Ardelyx, Inc.
$189
AKEBIA THERAPEUTICS INC
$173
Mallinckrodt Hospital Products Inc.
$156
VentureMed Group, Inc.
$153
Relypsa, Inc.
$144
BARD PERIPHERAL VASCULAR, INC.
$141
Travere Therapeutics, Inc.
$138
Medtronic, Inc.
$136
GlaxoSmithKline, LLC.
$123
Keryx Biopharmaceuticals, Inc.
$108
Covidien LP
$107
GENZYME CORPORATION
$101
Vifor Pharma, Inc.
$96
CorMedix Inc.
$88
CALLIDITAS THERAPEUTICS US INC.
$76
Philips Electronics North America Corporation
$71
Ultragenyx Pharmaceutical Inc.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
Novo Nordisk Inc
$54
Shire North American Group Inc
$49
Melinta Therapeutics, Inc.
$45
Merck Sharp & Dohme Corporation
$42
Allergan Inc.
$33
Outset Medical Inc
$29
NxStage Medical, Inc.
$27
AMAG Pharmaceuticals, Inc.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$22
Daiichi Sankyo Inc.
$22
Alexion Pharmaceuticals, Inc.
$21
ANI Pharmaceuticals, Inc.
$21
Retrophin, Inc.
$16
Janssen Pharmaceuticals, Inc
$16
Allergan, Inc.
$12
Top 3 companies account for 39.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AURYXIA · AVYCAZ · Auryxia · BENLYSTA · Baxdela · CABLIVI · CRYSVITA · DALVANCE · DefenCath · Dialyzers · Dojolvi · ELLIPSYS VASCULAR ACCESS SYSTEM · ENTRESTO · FARXIGA · FERAHEME · FLEX Vessel Prep System · Fabhalta · GATTEX · IBSRELA · IGT_D Coronary · INJECTAFER · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LIBERTY SELECT CYCLER · LOKELMA · LUPKYNIS · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · ReliaTack · Renal - Prismaflex System · Rybelsus · SAMSCA · SOLIRIS · TARPEYO · TAVNEOS · TEFLARO · TERLIVAZ · TRADJENTA · Tavneos · Vabomere · Velphoro · Veltassa · XARELTO · XPHOZAH 30 MG · ZEPATIER
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Emergency medicines in nearby ZIP areas
528
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
LAUREL RIDGE TREATMENT CENTER
5.9 mi
5.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alvarez is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alvarez experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Alvarez performed 392 chronic care management, first 20 min/month services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alvarez receive payments from pharmaceutical companies?
Yes. Dr. Alvarez received a total of $10,390 from 45 companies across 391 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alvarez's costs compare to other emergency medicines in Live Oak?
Dr. Alvarez's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alvarez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Emergency Medicines in Live Oak
Browse emergency medicines in Live Oak ranked by procedure volume and transparency data.
Highest volume
Top Emergency Medicines in TX
Emergency medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Emergency Medicines in TX
Which TX emergency medicines receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology